{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:50:01Z","timestamp":1789037401545,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","ejradiology.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejrad.2024.111439","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:15:25Z","timestamp":1711239325000},"page":"111439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"175","author":[{"given":"Xiu-Yun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejrad.2024.111439_b0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J Hepatol."},{"issue":"4","key":"10.1016\/j.ejrad.2024.111439_b0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.15403\/jgld.2014.1121.244.chl","article-title":"Clinical diagnosis and staging of intrahepatic Cholangiocarcinoma","volume":"24","author":"Bartella","year":"2015","journal-title":"J Gastrointestin Liver Dis."},{"key":"10.1016\/j.ejrad.2024.111439_b0015","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, et al. The Evaluation of the Eighth Edition of the AJCC\/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System. J Gastrointest Surg. 2020;24(4):786-95.","DOI":"10.1007\/s11605-019-04185-1"},{"issue":"1","key":"10.1016\/j.ejrad.2024.111439_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/hbsn.2016.10.02","article-title":"Staging of intrahepatic cholangiocarcinoma","volume":"6","author":"Ronnekleiv-Kelly","year":"2017","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J Hepatol."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10.1016\/j.ejrad.2024.111439_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"Brindley","year":"2021","journal-title":"Cholangiocarcinoma. Nat Rev Dis Primers."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"issue":"9","key":"10.1016\/j.ejrad.2024.111439_b0045","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","article-title":"Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival","volume":"20","author":"Jarnagin","year":"2009","journal-title":"Ann Oncol."},{"issue":"11","key":"10.1016\/j.ejrad.2024.111439_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12032-015-0692-x","article-title":"Cholangiocarcinoma: from molecular biology to treatment","volume":"32","author":"Brito","year":"2015","journal-title":"Med Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer."},{"issue":"11","key":"10.1016\/j.ejrad.2024.111439_b0060","article-title":"Early assessment of chemoradiotherapy response for locally advanced pancreatic ductal Adenocarcinoma by dynamic contrast-enhanced ultrasound","volume":"12","author":"Lu","year":"2022","journal-title":"Diagnostics (basel)"},{"issue":"7","key":"10.1016\/j.ejrad.2024.111439_b0065","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41571-019-0169-5","article-title":"The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches","volume":"16","author":"Gerwing","year":"2019","journal-title":"Nat Rev Clin Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.23736\/S1824-4785.17.03038-2","article-title":"Advances in oncological treatment: limitations of RECIST 1.1 criteria","volume":"62","author":"Grimaldi","year":"2018","journal-title":"Q J Nucl Med Mol Imaging."},{"issue":"4","key":"10.1016\/j.ejrad.2024.111439_b0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CH-201085","article-title":"Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma","volume":"77","author":"Dong","year":"2021","journal-title":"Clin Hemorheol Microcirc."},{"issue":"4","key":"10.1016\/j.ejrad.2024.111439_b0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0032-1313026","article-title":"An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion","volume":"33","author":"Dietrich","year":"2012","journal-title":"Ultraschall Med."},{"issue":"22","key":"10.1016\/j.ejrad.2024.111439_b0085","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.3748\/wjg.v24.i22.2348","article-title":"Noninvasive imaging of hepatocellular carcinoma: from diagnosis to prognosis","volume":"24","author":"Jiang","year":"2018","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.ejrad.2024.111439_b0090","article-title":"EFSUMB technical review - update 2023: dynamic contrast-enhanced ultrasound (DCE-CEUS) for the quantification of tumor perfusion","author":"Dietrich","year":"2023","journal-title":"Ultraschall Med"},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7863\/ultra.34.2.179","article-title":"Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion","volume":"34","author":"Frohlich","year":"2015","journal-title":"J Ultrasound Med."},{"issue":"4","key":"10.1016\/j.ejrad.2024.111439_b0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/CH-221681","article-title":"VueBox(R) perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules","volume":"83","author":"Huang","year":"2023","journal-title":"Clin Hemorheol Microcirc."},{"issue":"3","key":"10.1016\/j.ejrad.2024.111439_b0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/CH-190786","article-title":"Clinical application of dynamic contrast enhanced ultrasound in monitoring the treatment response of chemoradiotherapy of pancreatic ductal adenocarcinoma","volume":"75","author":"Zhang","year":"2020","journal-title":"Clin Hemorheol Microcirc."},{"issue":"10","key":"10.1016\/j.ejrad.2024.111439_b0110","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.hpb.2018.04.005","article-title":"Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma","volume":"20","author":"Sasaki","year":"2018","journal-title":"HPB (oxford)."},{"issue":"7","key":"10.1016\/j.ejrad.2024.111439_b0115","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00432-020-03200-2","article-title":"Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19\u20139 with cross-sectional imaging","volume":"146","author":"Hahn","year":"2020","journal-title":"J Cancer Res Clin Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jgh.13059","article-title":"Prognostic value of CA 19\u20139 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma","volume":"31","author":"Lee","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.ejrad.2024.111439_b0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40364-021-00306-8","article-title":"Imaging biomarkers for evaluating tumor response: RECIST and beyond","volume":"9","author":"Ko","year":"2021","journal-title":"Biomark Res."},{"issue":"4","key":"10.1016\/j.ejrad.2024.111439_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/CH-211261","article-title":"VueBox(R) for quantitative analysis of contrast-enhanced ultrasound in liver tumors1","volume":"80","author":"Dong","year":"2022","journal-title":"Clin Hemorheol Microcirc."},{"issue":"1","key":"10.1016\/j.ejrad.2024.111439_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2303-9027.193595","article-title":"Dynamic contrast-enhanced endoscopic ultrasound: a quantification method","volume":"6","author":"Dietrich","year":"2017","journal-title":"Endosc Ultrasound."},{"issue":"2","key":"10.1016\/j.ejrad.2024.111439_b0140","article-title":"Dynamic contrast-enhanced ultrasound of colorectal liver metastases as an imaging modality for Early response prediction to chemotherapy","volume":"7","author":"Mogensen","year":"2017","journal-title":"Diagnostics (basel)"},{"issue":"1","key":"10.1016\/j.ejrad.2024.111439_b0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1148\/radiol.10091870","article-title":"Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification\u2013preliminary results","volume":"258","author":"Lassau","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2024.111439_b0150","doi-asserted-by":"crossref","unstructured":"Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol. 2013;201(4):W603-11.","DOI":"10.2214\/AJR.12.10262"},{"issue":"4","key":"10.1016\/j.ejrad.2024.111439_b0155","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00261-012-9974-3","article-title":"Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics","volume":"38","author":"Nanashima","year":"2013","journal-title":"Abdom Imaging."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:20:59Z","timestamp":1729092059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X24001554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"alternative-id":["S0720048X24001554"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111439","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111439"}}